PROCEPT BioRobotics Corp
Company Stats
- Market Cap
- $1.0B
- as of Sep 30, 2026
- Enterprise Value
- $809.0M
- Shares Outstanding
- 57.3M
- Free Float
- 86.3%
Income Statement
- Revenue
- $308.1M
- Operating Income
- -$103.9M
- Net Income
- -$95.6M
- EBITDA
- -$97.5M
- Revenue Growth, 3Y
- 60.1%
- FCF Margin, 3Y Avg
- -54.3%
- FCF Margin, Worst Year
- -97.8%
Cash Flow
- Free Cash Flow
- -$58.3M
- FCF Yield
- -5.6%
- Owner FCF Yield
- -10.2%
Balance Sheet
- Cash & Equivalents
- $286.5M
- Total Debt
- $52.0M
- Net Cash
- $234.5M
Returns & Capital
- SBC, 3Y Avg
- $32.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $308.1M | -$58.3M | -18.9% |
| FY2024 | $224.5M | -$103.6M | -46.2% |
| FY2023 | $136.2M | -$133.2M | -97.8% |
| FY2022 | $75.0M | -$83.0M | -110.7% |
| FY2021 | $34.5M | -$57.9M | -168.0% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back